A hypoglossal nerve stimulator implant is a device surgically placed inside the body to treat obstructive sleep apnea.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $215.54, a high ...

This outpatient surgery involves an implant that stimulates the hypoglossal ... is very likely to pay for all or most of the ...

The Inspire procedure is an advanced outpatient treatment that uses a small implant to gently stimulate airway muscles during ...

DALLAS — For more information visit enttx.com/inspire.

The results surpassed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.

Inspire Medical Systems Inc. announced that Dr. Paul T. Hoff has joined the company as vice president and senior medical ...

Inspire Medical Systems, Inc. ( NYSE: INSP) Q1 2025 Results Conference Call May 5, 2025 5:00 PM ET Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

The company continues to focus on innovation and patient outcomes in the sleep apnea treatment ... rates for the Inspire 5 therapy, UBS believes the ease of the implant procedure could encourage ...